Investment Research & Advisory Group’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48K Buy
1,000
+400
+67% +$592 ﹤0.01% 217
2025
Q1
$1.54K Buy
+600
New +$1.54K ﹤0.01% 223